Introduction Executive Summary Narcolepsy: Overview ● Causes ● Mechanism of Action ● Signs and Symptoms ● Diagnosis ● Disease Management Pipeline Therapeutics ● Comparative Analysis Therapeutic Assessment ● Assessment by Product Type ● Assessment by Stage and Product Type ● Assessment by Route of Administration ● Assessment by Stage and Route of Administration ● Assessment by Molecule Type ● Assessment by Stage and Molecule Type Narcolepsy – DelveInsight’s Analytical Perspective In-depth Commercial Assessment ● Narcolepsy companies’ collaborations, Licensing, Acquisition -Deal Value Trends Narcolepsy Collaboration Deals ● Company-Company Collaborations (Licensing / Partnering) Analysis ● Company-University Collaborations (Licensing / Partnering) Analysis Late Stage Products (Preregistration) ● Comparative Analysis Sodium Oxybate (FT218): Avadel Pharmaceuticals ● Product Description ● Research and Development ● Product Development Activities Drug profiles in the detailed report….. Mid Stage Products (Phase II) ● Comparative Analysis Samelisant: Suven Life Sciences ● Product Description ● Research and Development ● Product Development Activities Drug profiles in the detailed report….. Early Stage Products (Phase I/II) ● Comparative Analysis TAK-925: Takeda ● Product Description ● Research and Development ● Product Development Activities Drug profiles in the detailed report….. Preclinical Stage Products ● Comparative Analysis Drug Name: Company Name ● Product Description ● Research and Development ● Product Development Activities Drug profiles in the detailed report….. Inactive Products ● Comparative Analysis Narcolepsy Key Companies Narcolepsy Key Products Narcolepsy- Unmet Needs Narcolepsy- Market Drivers and Barriers Narcolepsy- Future Perspectives and Conclusion Narcolepsy Analyst Views Narcolepsy Key Companies Appendix

Table 1 Total Products for Narcolepsy Table 2 Late Stage Products Table 3 Mid Stage Products Table 4 Early Stage Products Table 5 Pre-clinical & Discovery Stage Products Table 6 Assessment by Product Type Table 7 Assessment by Stage and Product Type Table 8 Assessment by Route of Administration Table 9 Assessment by Stage and Route of Administration Table 10 Assessment by Molecule Type Table 11 Assessment by Stage and Molecule Type Table 12 Inactive Products

• Axsome Therapeutics • Jazz Pharmaceuticals • Takeda • Suven Life Sciences • Axsome Therapeutics